• Corpus ID: 70479995

Toxic Love: soy baby formula, healthy alternative or unnecessary harm?

  title={Toxic Love: soy baby formula, healthy alternative or unnecessary harm?},
  author={Eva Evguenieva},


Health committee warns of potential dangers of soya
A committee of experts has advised that adults who eat soya products do so in moderation, pending authoritative future studies, although research showing possible harm from soya is based on animal or retrospective human studies.
Herbal Medicines, Phytoestrogens and Toxicity: Risk: Benefit Considerations 1
  • D. Sheehan
  • Medicine
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1998
Among human exposures, infant soy formula exposure appears to provide the highest of all phytoestrogen doses, and this occurs during development, often the most sensitive life-stage for induction of toxicity.
Soy infant formula and phytoestrogens
  • P. Tuohy
  • Biology
    Journal of paediatrics and child health
  • 2003
Despite the absence of adequate scientific research that quantifies the level of risk to infants, most would argue for a precautionary approach to be taken in situations where there are potential developmental effects from the consumption of pharmacologically active compounds in infancy and childhood.
Conflicts of Interest and Hyperbole: Nutrition in the Media
Providing training in health sciences to undergraduate journalism and mass communication students will give future health reporters the solid foundation they need to communicate health news effectively to the public.
Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood.
Exposure to soy formula does not appear to lead to different general health or reproductive outcomes than exposure to cow milk formula, and the findings are reassuring about the safety of infant soy formula.
Oral Exposure to Genistin, the Glycosylated Form of Genistein, during Neonatal Life Adversely Affects the Female Reproductive System
The results support the idea that the dose of the physiologically active compound reaching the target tissue, rather than the administered dose or route, is most important in modeling chemical exposures.
Bioavailability of soy isoflavones through placental/lactational transfer and soy food.
  • D. Doerge
  • Biology
    Toxicology and applied pharmacology
  • 2011
Lost in transmission--FDA drug information that never reaches clinicians.
Drs. Lisa Schwartz and Steven Woloshin write that much critical information that the FDA has at the time of approval may fail to make its way into the drug label and relevant journal articles.
Use of Soy Protein-Based Formulas in Infant Feeding
The limited indications and contraindications of soy formulas, the potential harmful effects of soy protein-based formulas and the phytoestrogens contained in these formulas are reviewed.
FDA science base badly eroded: but will congress provide urgent new funding?
  • S. Barlas
  • Political Science
    P & T : a peer-reviewed journal for formulary management
  • 2008
The scientific mesh used to sift through new drugs has more holes than the U.S. border with Mexico, and given the cascading headlines accorded to big-name drugs with big-time problems, the FDA’s serious scientific shortcomings may become almost as huge a political concern as immigration.